Press-release for stocks related to pharma

| -46.66% | O: 4.59% H: 0.0% C: -2.55%
pharma application trial lucid-ms lucid-21-302 phase 1

Corium Pharma Solutions Appoints Mark Sirgo as Chief Executive Officer
Published: 2023-01-17 (Crawled : 14:00) - biospace.com/
GNTA | $2.55 -29.75% 1.09% 1

| -60.47% | O: -0.62% H: 0.62% C: 0.62%
PG A | $162.6 0.68% -0.15% 11K

Consumer Non-Durables

| 7.77% | O: -0.06% H: 0.89% C: -0.23%
COLL | $35.48 -1.28% -1.27% 88

| 23.49% | O: -1.01% H: 1.93% C: -0.18%
AGRX | $0.4003 74K

| -97.24% | O: 2.93% H: 0.5% C: -3.79%
NMTR | $0.0722 -42.97% -67.9% 10M

| -96.9% | O: 0.43% H: 0.0% C: -5.56%
pharma solutions

FSD Pharma Announces Share Repurchase Program
Published: 2023-01-13 (Crawled : 18:00) - fsdpharma.com
HUGE | News | $0.4589 -2.15% -1.21% 220K

| -43.75% | O: 8.61% H: 1.43% C: -2.9%
pharma repurchase program

FSD Pharma Announces Share Repurchase Program - January 13, 2023
Published: 2023-01-13 (Crawled : 17:00) - biospace.com/
HUGE | News | $0.4589 -2.15% -1.21% 220K

| -43.75% | O: 8.61% H: 1.43% C: -2.9%
pharma repurchase program

Acasti Pharma to Present at Sidoti Virtual Investor Conference on January 18
Published: 2023-01-13 (Crawled : 14:20) - globenewswire.com
ACST | $2.9 0.69% 4.64% 4

| -31.85% | O: 1.52% H: 0.0% C: -1.39%
pharma conference

Autoimmune Patient Perspective on the Corporate Reputation of Pharma Companies, 2021-2022: The Views of 293 Patient Groups - Pfizer Ranked 1st, AbbVie Ranked 2nd, Novartis Ranked 3rd
Published: 2023-01-13 (Crawled : 12:00) - prnewswire.com
SNYNF | News | $94.0 -0.27% -2.18% 0

| -5.39% | O: -0.13% H: 0.76% C: 0.76%
SNY | News | $46.61 -2.27% -2.21% 220K

| -1.9% | O: 1.89% H: 0.0% C: 0.0%
pharma abbvie novartis

Corporate Reputation of Pharma Companies in United States, 2021-2022: The Views of 240 Patient Groups - ViiV Healthcare Ranked 1st, Horizon Therapeutics Ranked 2nd and Pfizer Ranked 3rd
Published: 2023-01-13 (Crawled : 11:00) - prnewswire.com
SNYNF | News | $94.0 -0.27% -2.18% 0

| -5.39% | O: -0.13% H: 0.76% C: 0.76%
SNY | News | $46.61 -2.27% -2.21% 220K

| -1.9% | O: 1.89% H: 0.0% C: 0.0%
pharma companies therapeutics

Alvotech and Fuji Pharma Expand Partnership Adding a New Biosimilar Candidate
Published: 2023-01-13 (Crawled : 10:00) - globenewswire.com
ALVO | $13.54 1.9K

| 12.83% | O: 0.42% H: 7.8% C: 4.56%
KMDA | $5.18 1.57% 1.16% 7

| 2.17% | O: -0.59% H: 0.79% C: 0.59%
partnership pharma candidate biosimilar

Midatech Pharma PLC Announces Planned Dose Escalation in MTX-110 Phase 1 Study
Published: 2023-01-12 (Crawled : 11:00) - biospace.com/
MTP | $0.4703 -70.79% -73.69% 0

| -58.65% | O: 17.33% H: 0.43% C: -23.86%
mtx-110 pharma study phase 1

Syneos Health Announces Partnership with Fosun Pharma USA to Launch SerplulimabRelationship Will Leverage Syneos One Expertise, Accessing Clinical and Commercial Solutions
Published: 2023-01-11 (Crawled : 13:00) - biospace.com/
SYNH | $42.98 0.0% 7.4M

Health Services

| 21.62% | O: 3.59% H: 0.0% C: -5.9%
partnership pharma solutions commercial health one

The Corporate Reputation of Pharma Companies in Canada, 2021-2022 from The Patient Perspective - Focus on R&D, Transparency, Drug pricing, Patient Access to Medicines
Published: 2023-01-11 (Crawled : 13:00) - prnewswire.com
SNYNF | News | $94.0 -0.27% -2.18% 0

| -3.49% | O: -0.01% H: 0.0% C: 0.0%
SNY | News | $46.61 -2.27% -2.21% 220K

| -1.93% | O: 0.35% H: 0.0% C: 0.0%
pharma drug companies

Global CDMO Adare Pharma Solutions Harmonizing Quality with Veeva Vault Quality Suite
Published: 2023-01-11 (Crawled : 12:20) - prnewswire.com
VEEV | $195.51 -2.5% 32K

Technology Services

| 24.39% | O: 0.71% H: 1.83% C: 1.83%
pharma global solutions

Syneos Health Announces Partnership with Fosun Pharma USA to Launch Serplulimab
Published: 2023-01-11 (Crawled : 12:20) - globenewswire.com
SYNH | $42.98 0.0% 7.4M

Health Services

| 21.62% | O: 3.59% H: 0.0% C: -5.9%
partnership pharma health

Silo Pharma Advances Clinical Study Analyzing Effects of Psilocybin on Inflammation
Published: 2023-01-10 (Crawled : 15:20) - globenewswire.com
SILO | $1.88 5.62% 6.32% 13K

Finance and Insurance

| -36.91% | O: 0.67% H: 13.33% C: -3.67%
pharma study psilocybin

Ocuphire Pharma Announces First Patient Enrolled in VEGA-2 Pivotal Phase 3 Trial of Nyxol® in Presbyopia
Published: 2023-01-09 (Crawled : 23:00) - biospace.com/
OCUP | News | $1.53 -0.65% -1.32% 0

| -51.74% | O: 1.89% H: 5.26% C: 5.26%
nyxol pharma trial presbyopia

Royalty Pharma Highlights Accomplishments and Provides Business Update at 41st Annual J.P. Morgan Healthcare Conference
Published: 2023-01-09 (Crawled : 15:00) - globenewswire.com
JNJ | News | $148.53 -0.69% 0.11% 67K

| -17.81% | O: -0.53% H: 0.26% C: -2.07%
RPRX | $27.98 0.58% 0.57% 6

| -26.54% | O: 0.53% H: 3.12% C: 2.38%
pharma royalty conference update

Inozyme Pharma Announces Investor and Analyst Event and Highlights 2022 Progress
Published: 2023-01-09 (Crawled : 14:20) - biospace.com/
INZY | $4.4 0.0% 1

| 136.56% | O: 1.61% H: 4.5% C: -11.11%
pharma

Ionis and Royalty Pharma enter into royalty agreement for up to $1.1 billion to further advance Ionis' genetic medicines and commercial readiness
Published: 2023-01-09 (Crawled : 14:20) - prnewswire.com
JNJ | News | $148.53 -0.69% 0.11% 67K

| -17.81% | O: -0.53% H: 0.26% C: -2.07%
RPRX | $27.98 0.58% 0.57% 6

| -26.54% | O: 0.53% H: 3.12% C: 2.38%
IONS | $42.45 1.46% 1.45% 1.6K

| 4.76% | O: -0.17% H: 0.84% C: -7.91%
pharma royalty commercial genetic agreement

Royalty Pharma and Ionis Enter Into Royalty Agreement for Up to $1.1 Billion to Further Advance Ionis’ Genetic Medicines and Commercial Readiness
Published: 2023-01-09 (Crawled : 14:20) - globenewswire.com
JNJ | News | $148.53 -0.69% 0.11% 67K

| -17.81% | O: -0.53% H: 0.26% C: -2.07%
RPRX | $27.98 0.58% 0.57% 6

| -26.54% | O: 0.53% H: 3.12% C: 2.38%
IONS | $42.45 1.46% 1.45% 1.6K

| 4.76% | O: -0.17% H: 0.84% C: -7.91%
pharma royalty commercial genetic agreement

FSD Pharma Inc Incorporates New Subsidiary to Capitalize on Drug Development Incentives in Australia
Published: 2023-01-09 (Crawled : 14:00) - biospace.com/
HUGE | News | $0.4589 -2.15% -1.21% 220K

| -39.05% | O: -0.13% H: 9.9% C: 2.98%
pharma drug australia

← Previous
1
2
…
47
48
49
50
51
52
53
54
55
…
121
122
Next →

Gainers vs Losers

50%

Top 10 Gainers

CSSE 4 | $0.299 96.32% 7M

Consumer Services

BRFH 4 | $1.99 80.91% 13M

Manufacturing

BOF | $1.915 63.68% 620K

AMST | $3.13 56.5% 500K

Technology Services

ACON | $0.3595 24.83% 3.5M

CDTX | News | $14.57 18.55% 330K

ULBI M | $10.12 15.92% 120K

Producer Manufacturing

LRHC | $1.79 11.88% 3K

AIXI | $1.34 8.94% 42K